CVS.DECVS.DEXETRA
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +4.15% | +6.96% | +8.89% | +7.80% | +8.17% |
| Gross Profit Growth | -7.04% | +14.61% | +4.65% | +9.94% | +5.18% |
| EBITDA Growth | -11.00% | +32.67% | -15.14% | -177.50% | -18.43% |
| Operating Income Growth | -29.80% | +48.57% | -21.81% | -485.46% | -10.81% |
| Net Income Growth | -19.65% | +59.84% | -42.32% | -4668.97% | +79.01% |
| EPS Growth | -17.61% | +60.23% | -42.55% | -4629.67% | +76.34% |
| EPS Diluted Growth | -17.72% | +60.23% | -42.55% | -4629.67% | +76.92% |
| Weighted Average Shares Growth | -2.25% | +0.08% | +0.40% | +0.79% | +0.87% |
| Weighted Average Shares Diluted Growth | -2.40% | -0.24% | +0.40% | +0.79% | +1.19% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -7.08% | -38.59% | +0.00% | +82.26% |
| Free Cash Flow Growth | +0.00% | -9.17% | -47.37% | +0.00% | +138.64% |
| Receivables Growth | +3.53% | +22.99% | +185.81% | +21.22% | +9.08% |
| Inventory Growth | +0.45% | +0.00% | +8.58% | +7.44% | +6.29% |
| Asset Growth | +1.40% | +2.34% | +2.32% | +1.15% | +0.13% |
| Book Value per Share Growth | +1.10% | +3.92% | +2.86% | -3.46% | -1.32% |
| Debt Growth | +4.45% | -0.71% | -1.31% | -1.15% | -3.58% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +0.76% | -100.00% | -100.00% | +0.00% | -100.00% |